Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y, Gabelt BT, Kaufman PL, Hara H.
Exp Eye Res. 2004 Apr;78(4):767-76.PMID: 15037111 [PubMed - indexed for MEDLINE]Related articles